Pharmaceutical company.
Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs;
Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary" Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs;
Issues related to drug pricing, pricing transparency;
Issues related to pharmaceutical industry, generally
MMM - Medicare/Medicaid PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RICCHETTI INCORPORATED
601 13th Street, NW, Suite 630N, Washington, DC, 20005, US
JEFF RICCHETTI JEFF RICCHETTI